Why this Newsletter

Based on the recent Center for Medicare and Medicaid Services (CMS) publication, U.S. healthcare spending reached $5.3 trillion in 2024, a 7.2% increase from $4.9 trillion spent in 2023.

****

In 2024, healthcare spending made up 18% of the U.S. GDP, up from 17.7% in 2023. The growth in healthcare spending between 2023 and 2024 reflected both increased use and intensity of healthcare goods, supplies and services.

Spending on hospital care took up the largest share of healthcare spending at 31% or $1.6 trillion in 2024. This reflects an 8.9% increase from $1.5 trillion the previous year.

Physician and clinical services were estimated to be 21% of total healthcare spending representing $1.1 trillion, an 8.1% increase from $1 trillion spent in 2023.

Retail prescription drug spending at 9% of 2024 total healthcare spending was $427 billion, a 7.9% increase from the prior year. The 7.9% year-over-year increase for the 2023-2024 period is less when compared to the 10.8% year-over-year increase noted in the 2022-2023 period.

The insured share of the U.S. population reached 92.5% in 2023, compared with 91.8% in 2024. Center for Medicare and Medicaid Services study noted that in 2024, Medicaid enrollment declined amid enrollment gains in marketplace plans and employer-sponsored private health insurance.

****

About Rowinski Group

2026 marks the 22nd year in business for Rowinski Group LLC. Rowinski Group is a global reimbursement and healthcare payer data analytics consultancy for medical devices, digital health and diagnostics companies who are developing and selling their medical technology for the U.S healthcare market.

Rowinski Group has offices in Silicon Valley – San Francisco Bay area and Chicago, Minneapolis, and Portland.

Rowinski Group has two core service offerings; securing codes and reimbursement on behalf of our company clients and using healthcare payer data analytics to help our companies solve their business issues like responding to questions from the FDA and Medicare, sales forecasting, building marketing models, Key Opinion Leader (KOL) identification.

Through these service offerings Rowinski Group helps companies from around the work to establish and build their U.S. market share.

For more information visit https://reimbursement.consulting  or contact Daniel Zimmerman d.zimmerman@reimbursement.consulting.